行情

ONTX

ONTX

Onconova医疗
NASDAQ

实时行情|Nasdaq Last Sale

1.800
-0.325
-15.29%
盘后: 1.640 -0.16 -8.89% 19:59 09/17 EDT
开盘
2.000
昨收
2.125
最高
2.000
最低
1.760
成交量
46.49万
成交额
--
52周最高
11.17
52周最低
1.690
市值
1,079.73万
市盈率(TTM)
-0.4707
分时
5日
1月
3月
1年
5年

分析师评级

4位分析师的综合评级

买入

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

EPS

ONTX 新闻

  • 日本8月出口连续9个月下滑 对华出口连降6个月
  • 新浪财经.4小时前
  • 世行行长:全球经济减速率超出估计
  • 新浪财经综合.4小时前
  • 新债王冈拉克:美债收益率已触底 别押注低利率
  • 新浪财经.4小时前
  • 美股地产股领涨能源股垫底 美联储降息概率进一步降低
  • 新浪科技.5小时前

更多

所属板块

制药
+0.65%
制药与医学研究
+0.57%

热门股票

名称
价格
涨跌幅

ONTX 简况

Onconova Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company operates through the identification and development of oncology therapeutics segment. It is focused on discovering and developing small molecule drug candidates to treat cancer. The Company has created a targeted anti-cancer agents designed to work against specific cellular pathways that are important to cancer cells. It has over three clinical-stage product candidates and various preclinical programs that target kinases, cellular metabolism or cell division in preclinical development. The Company's lead product candidate, rigosertib, is being tested in both intravenous (IV) and oral formulations as a single agent, and the oral formulation is also being tested in combination with azacitidine, in clinical trials for patients with myelodysplastic syndromes (MDS), and related cancers. Its other product candidates include Briciclib and Recilisib.
展开

Webull提供Onconova Therapeutics Inc的股票价格,实时市场报价,专业分析师评级,深度图表和免费的股票新闻,以帮助您做出投资决策。